NASDAQ:ESLA | Free Cash Flow | Estrella Immunopharma, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2021-03-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$6.7M
2025-12-31-$177,487.00
2025-03-31-$465,981.00
2024-09-30-$2.22M
2024-06-30-$291,513.00
2024-03-31-$4.23M
2023-09-30-$275,192.00
2023-06-30-$43,245.00
2023-03-31-$275,718.00
2022-12-31-$140,132.00
2022-09-30-$1.1M
2022-03-31-$157,144.00
2021-12-31-$293,300.00
2021-03-31-$819.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$1.79M
2024-06-30-$16.07M
2023-06-30-$1.34M
2022-12-31-$1.04M
2021-12-31-$316,158.00